We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Diagnostics – Webinars and Online Events

TN webinar seer bio 23rd May 2024
Webinar

Plasma Proteome Profiling for Lung Cancer Biomarker Discovery

In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.
The Landscape of Cancer Research: Advances in Immuno-oncology
Online Event

The Landscape of Cancer Research: Advances in Immuno-oncology 2024

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.
Cell and Gene Therapy Symposium, March 20-21: Experts discuss cancer immunotherapy, gene vectors, stem cells, and precision oncology
Online Event

Cell and Gene Therapy 2024

On-Demand
Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.
Harnessing the Power of ddPCR to Advance Precision Oncology
Webinar

Harnessing the Power of ddPCR to Advance Precision Oncology

On-Demand
Liquid biopsies and the advent of blood-based diagnostics have emerged in recent years as promising alternatives and complements to tissue-based genomic and proteomic assays. Biodesix, a global leader in molecular diagnostics and assay design/development, leverages cutting-edge technology, including droplet digital PCR (ddPCR), to advance translational and clinical oncology research and to assist biopharma companies in delivering new, targeted, life-saving therapies to patients.

This presentation provides a comprehensive exploration of new blood-based diagnostics, including the development of a microsatellite instability (MSI) test on the ddPCR platform and the dynamic monitoring capabilities of ddPCR using circulating tumor DNA (ctDNA).
The Most Comprehensive Insights in Cancer Genomes: Translational Research content piece image
Webinar

The Most Comprehensive Insights in Cancer Genomes: Translational Research

On-Demand
This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.
The Landscape of Cancer Research 2021 content piece image
Online Event

The Landscape of Cancer Research 2021

On-Demand
Accessed via mobile, tablet or PC, this free-to-attend inaugural online symposium will provide cancer researchers with a unique opportunity to hear about the advances taking place within omics research, immunology, drug discovery and other notable topics.
Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq content piece image
Webinar

Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq

On-Demand
Watch this webinar to hear how researchers use scRNA-seq to develop a working model for combinational therapeutics to delay development of ITH and much more.
Advertisement